Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer

Jarred P. Reed, Suzanne Devkota, Robert A. Figlin

Abstract

Immune checkpoint inhibitors (ICIs) have transformed the treatment of solid malignancies, but responses are heterogeneous with benefit generally limited to only a fraction of patients.